Navigation Links
Drug used to treat hypertension effective in countering Migraines

Migraines,headaches which involve intense throbbing pain, sometimes accompanied by visual disturbances as well as sensitivity to light and sounds, have been found to respond to a drug hitherto used to treat high blood pressure//.

Norwegian researchers reported that drugs like candesartan cilexetil (Atacand) reduces the number and severity of migraine attacks. The Norwegian team decided to study Atacand after a colleague in their department noticed his migraines disappeared when he started taking the drug lisinopril for his high blood pressure. The researchers reasoned that if the anti-migraine effect was linked to the lisinopril, which reduces the amount of angiotensin II, a drug such as Atacand, which works by blocking angiotensin II and called an angiotensin II receptor blocker, might be even more effective. Angiotensin II is a substance that constricts blood vessels and can make blood pressure rise.

The study involved 65 patients of ages 20 to 65, who experienced 2 to 6 attacks in a month. The researchers assigned 30 patients to take the placebo in the first 12 week period and a 16mg Atacand in the following 12 week period. The other group of 30 underwent the reverse of the above regime (ie. Atacand in the first 12 weeks and placebo in the next 12 weeks), though none of the groups were aware whether they were taking the placebo or the medicine.

Researchers found that during the 12 week periods, the average number of days with headaches was 18.5 with placebo and 13.6 with the medicine. 30 to 45 per cent of the subjects showed 50 per cent reduction in one of the outcome measures, like headache severity. The drug also a showed a reduction in the length of attacks, in addition to the reduction in the number of headache and migraine days.

The study, though very interesting and beneficial to the millions of migraine sufferers around the globe, has not been able to find out how these drugs work to reduce or prevent migraines . An expert neurologist says that the drug might presumably have multiple effects on multiple sites in the brain. The researchers also said that they do not have any predictors as yet, to who might respond to this type of medication and that they are trying to investigate this aspect, both with respect to blood pressure variations and to genetic variations.

The drug Atacand is manufactured by AstraZeneca, which provided the necessary medication and financial support for the study.
'"/>




Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. New drug to treat Heart Attack and damaged tissue
4. Now umbilical cord helps in stroke treatment.
5. Now AIDS treatment comes dirt-cheap
6. Breast cancer treatment to be determined by gene test
7. Hemopurifier may revolutionise AIDS treatment
8. New drug helps boost cancer treatment
9. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
10. Experimental treatment for Ebola Virus Shows promising results in mice
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2017)... ... February 19, 2017 , ... Orbita, Inc., a ... with Healthwise ® at HIMSS 2017 to showcase a breakthrough ... health education, technology and services, will demonstrate a voice-powered knowedge assistant based on ...
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken Matthews to visit ... Butler products. Ken was impressed with the safety and reliability of the Stannah ... on his show. This endorsement by Ken Matthews can be heard on News ...
(Date:2/18/2017)... ... February 18, 2017 , ... ProParagraph Fashion Volume 2 features ... ProParagraph Fashion Volume 2 for all multi-line FCPX project needs. Great for ... and choose from hand-crafted trend-setting designs with smooth animations that will add stylistic ...
(Date:2/17/2017)... ... February 17, 2017 , ... While EHR data ... has introduced an innovative workstation designed to reduce nursing fatigue while enhancing productivity. ... EHR Workstation offers a lightweight, highly mobile, multi-functional alternative to the limitations of ...
(Date:2/17/2017)... ... February 17, 2017 , ... For the first time, International ... the exhibit floor for the 2017 HIMSS Conference & Exhibition at ... 2017, more than 40,000 healthcare industry professionals are expected at the conference, where ...
Breaking Medicine News(10 mins):
(Date:2/18/2017)... 17, 2017 Research and Markets has announced the ... to their offering. ... report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , Latin America , and Rest ... through 2022. Also, a six-year historic analysis is provided for these markets. ...
(Date:2/17/2017)... 17, 2017 Arvinas LLC, a private biotechnology ... protein degradation, today announced the presentation of new preclinical ... a poster session at the American Society of Clinical ... Orlando, FL. "The ... and the potential of PROTACs to drive durable and ...
(Date:2/17/2017)... , Feb. 17, 2017   Risperdal lawsuits involving ... allegedly associated with use of the atypical antipsychotic medication ... Court of Common Pleas, where the state,s ... program. According to a notice posted on the ... a meeting on March 9, 2017 at 11:00 a.m. ...
Breaking Medicine Technology: